Ming Fu - Shandong Weigao Independent Non-Executive Director

SHWGF Stock  USD 0.96  0.00  0.00%   

Director

Ms. Fu Ming Zhong is Independent NonExecutive Director of Shandong Weigao Group Medical Polymer Company Limited. She is the senior economist and associate chief pharmacist and has over 40 years of working experience, particular in the area of management experience in the pharmaceutical and healthcare products industry. Mrs. Fu obtained a masters degree in engineering from the Harbin Institute of Technology in March 1992. Mrs. Fu was previously a deputy workshop director, the office head and the vice factory manager of The Third Harbin Pharmaceutical Factory from June 1972 to March 1999. Mrs. Fu was a director of Harbin City Pharmaceutical Group and the general manager of Harbin Pharmaceutical Company Limited from March 1992 to December 1997. She was also a deputy general manager of China Medicines Group from December 1997 to January 1999 and she was a director of China Medicines Group Corporation from January 1999 to July 2009 respectively. Mrs. Fu was the executive deputy general manager of China National Pharmaceutical industry Corporation from January 1999 to January 2001. Ms. Fu was the chairman of National Medicines Company Limited from February 2001 to April 2008. Mrs. Fu was a director of Shenzhen Accord Pharmaceutical Company Ltd. since April 2008 and was the chairman from April 2008 to December 2008. Ms. Fu has also been a director of Sinopharm Industrial Investment Co., Ltd. from July 2008 to December 2010. Mrs. Fu was the general manager, duty chairman and director of Sinopharm Group Co. Ltd. during the period from February 2006 to December 2009, and December 2009 to January 2011 respectively. Mrs. Fu is currently the chairman of China Association of Pharmaceutical Commerce and she joined the Company in October 2011. since 2011.
Age 66
Tenure 13 years
Phone86 63 1562 1999
Webhttps://www.weigaogroup.com

Shandong Weigao Management Efficiency

The company has return on total asset (ROA) of 0.0604 % which means that it generated a profit of $0.0604 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1276 %, meaning that it generated $0.1276 on every $100 dollars invested by stockholders. Shandong Weigao's management efficiency ratios could be used to measure how well Shandong Weigao manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 3.46 B in total debt with debt to equity ratio (D/E) of 0.2, which may suggest the company is not taking enough advantage from borrowing. Shandong Weigao Group has a current ratio of 2.93, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Shandong Weigao until it has trouble settling it off, either with new capital or with free cash flow. So, Shandong Weigao's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Shandong Weigao Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Shandong to invest in growth at high rates of return. When we think about Shandong Weigao's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Margaret WhitmanProcter Gamble
64
Andrew RubinJD Sports Fashion
52
James McNerneyProcter Gamble
65
Patricia WoertzProcter Gamble
67
Gary SullivanDelek Logistics Partners
67
Heather JacksonJD Sports Fashion
51
Shangning QianYuexiu Transport Infrastructure
51
Susan DesmondHellmannProcter Gamble
57
Francis DAndreaDelek Logistics Partners
66
Hon LauYuexiu Transport Infrastructure
67
Amy ChangProcter Gamble
44
John ChevalierProcter Gamble
N/A
Francis BlakeProcter Gamble
70
Ernesto ZedilloProcter Gamble
62
Lee WeldonNatural Alternatives Internatio
78
Mark CoxDelek Logistics Partners
56
Assaf GinzburgDelek Logistics Partners
43
Eric GaddDelek Logistics Partners
65
Loudon OwenAcademy Sports OutdoorsInc
N/A
Joseph JimenezProcter Gamble
60
Ronald HaddockDelek Logistics Partners
81
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the Peoples Republic of China. The company was incorporated in 2000 and is based in Weihai, the Peoples Republic of China. Shandong Weigao operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 11476 people. Shandong Weigao Group [SHWGF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Shandong Weigao Group Leadership Team

Elected by the shareholders, the Shandong Weigao's board of directors comprises two types of representatives: Shandong Weigao inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shandong. The board's role is to monitor Shandong Weigao's management team and ensure that shareholders' interests are well served. Shandong Weigao's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shandong Weigao's outside directors are responsible for providing unbiased perspectives on the board's policies.
Junqiang Lu, Ex Director
Jia Li, Independent Non-Executive Director
Miu Wong, Company Secretary
Hong Ju, Vice-General Manager of the Production and Supply Chain
Hua Zhang, Vice Chairman, General Manager, Compliance Officer and Chairman of Corporate Governance Committee
Shu Zhou, Non-Executive Director
Jian Gong, Executive Director
Rinan Cong, CEO Director
Yi Wang, Deputy General Manager of General Affairs and Executive Director
Ming Fu, Independent Non-Executive Director
Jin Cui, CFO
Jinxia Wang, Independent Non-Executive Director
Jin Wang, Independent Non-Executive Director
Shili Ni, Ex Director
Xiu Song, Head - Sales Department
Wai Lo, Independent Non-Executive Director
Yuk Chan, Head - Business Development & Investor Relations
Xue Chen, Non-Executive Chairman of the Board
Lie Xia, Executive Director
De Zhou, Deputy General Manager - Blood Transfusion Division
Xue Wu, Chief Officer
Jing Long, Vice-General Manager of Marketing Management

Shandong Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Shandong Weigao a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shandong Weigao Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Shandong Weigao Group information on this page should be used as a complementary analysis to other Shandong Weigao's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Shandong Pink Sheet analysis

When running Shandong Weigao's price analysis, check to measure Shandong Weigao's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shandong Weigao is operating at the current time. Most of Shandong Weigao's value examination focuses on studying past and present price action to predict the probability of Shandong Weigao's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shandong Weigao's price. Additionally, you may evaluate how the addition of Shandong Weigao to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Please note, there is a significant difference between Shandong Weigao's value and its price as these two are different measures arrived at by different means. Investors typically determine if Shandong Weigao is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shandong Weigao's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.